@misc{10481/107818,
year = {2023},
month = {3},
url = {https://hdl.handle.net/10481/107818},
abstract = {The present invention provides antibodies, that bind to human CEACAM6 and are able to relieve CEACAM6-mediated immunosuppression, wherein said antibodies have reduced side-effects during treatment. The present invention further provides isolated nucleic acids encoding said antibodies and vectors comprising same, isolated cells expressing said antibodies, methods of producing said antibodies and pharmaceutical compositions and kits comprising said antibodies. Antibodies according to the present invention can be used to treat cancer and might be used to treat other disorders and conditions associated with the expression of the CEACAM6.},
organization = {Deutsches Krebsforschungzentrum},
publisher = {WIPO/PCT},
keywords = {CEACAM6},
keywords = {Antibody},
keywords = {Cancer},
title = {Anti-cecam6 antibodies with reduced side-effects},
author = {Carretero Coca, Rafael},
}